Partnering
Partnering
Cytospire knows that the translation of great science into medicines that matter is enhanced by collaboration with academic and other biopharmaceutical companies.
Cytospire’s current partners include:
We are open to new partnerships and collaborations to fully realise the potential of our pan-gamma delta engagers.
Interested in partnering with us?
Humanitas Research Hospital (ICH) in Milan is a distinguished Research and University Hospital, recognized for its nationally certified Research Institute and Humanitas University of Medicine – Hunimed. The hospital integrates four specialized clinical areas: Oncology, Cardiology, Neurology, and Orthopedics, positioning itself as one of the world’s leading hospitals in Innovation and Technology.
Cytospire has collaborated with the group of Professor Domenico Mavilio at Humanitas to show that our engagers can potently activate gamma delta T cells in patient samples, including tumor infiltrating lymphocytes.